Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/10/13 → 7/31/24 |
Funding
- Janssen Research and Development LLC: $452,181.00
12-NHL-18-JJ (PCI-32765MCL3002) Bendamustine-Rituximab +/- Ibrutinib for newly diagnosed Mantle Cell Lymphoma (SHINE)
- Fleischman, Roger (PI)
- Hayslip, John (Former PI)